Embecta Corp. (EMBC)

Market Cap	1.18B
Revenue (ttm)	1.12B
Net Income (ttm)	78.30M
Shares Out	58.13M
EPS (ttm)	1.34
PE Ratio	15.10
Forward PE	7.59
Dividend	$0.60 (2.97%)
Ex-Dividend Date	Dec 6, 2024

Volume	1,042,623
Open	19.70
Previous Close	19.97
Day's Range	19.30 - 20.44
52-Week Range	9.93 - 21.48
Beta	1.20
Analysts	Buy
Price Target	19.00 (-6.08%)
Earnings Date	Feb 7, 2025

About EMBC

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1924
• Employees: 2,200
• Stock Exchange: NASDAQ
• Ticker Symbol: EMBC
• Website: https://www.embecta.com

Financial Performance

In 2024, Embecta's revenue was $1.12 billion, an increase of 0.21% compared to the previous year's $1.12 billion. Earnings were $78.30 million, an increase of 11.22%.

Analyst Forecast

According to 2 analysts, the average rating for EMBC stock is "Buy." The 12-month stock price forecast is $19.0, which is a decrease of -6.08% from the latest price.

Price Target

$19.0

(-6.08% downside)

Analyst Consensus: Buy